Literature DB >> 20838769

Atypical femoral stress fractures in bisphosphonate-free patients.

Sok Chuen Tan, Suang Bee Joyce Koh, Seo Kiat Goh, Tet Sen Howe.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20838769     DOI： 10.1007/s00198-010-1384-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  2 in total

1.  Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

Authors:  Brett A Lenart; Dean G Lorich; Joseph M Lane
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

2.  Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.

Authors:  S-K Goh; K Y Yang; J S B Koh; M K Wong; S Y Chua; D T C Chua; T S Howe
Journal:  J Bone Joint Surg Br       Date:  2007-03
  2 in total
  19 in total

Review 1.  Review: epidemiology and pathophysiology of atypical femur fractures.

Authors:  Alvin C Ng; Meng Ai Png; David T Chua; Joyce S B Koh; Tet Sen Howe
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

2.  Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series.

Authors:  Satoshi Sasaki; Naohisa Miyakoshi; Michio Hongo; Yuji Kasukawa; Yoichi Shimada
Journal:  J Bone Miner Metab       Date:  2012-05-19       Impact factor: 2.626

Review 3.  Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications.

Authors:  Yoshitomo Saita; Muneaki Ishijima; Kazuo Kaneko
Journal:  Ther Adv Chronic Dis       Date:  2015-07       Impact factor: 5.091

Review 4.  Questioning the association between bisphosphonates and atypical femoral fractures.

Authors:  Michael Pazianas; Se-min Kim; Tony Yuen; Li Sun; Sol Epstein; Mone Zaidi
Journal:  Ann N Y Acad Sci       Date:  2014-10-07       Impact factor: 5.691

Review 5.  Disentangling the emerging evidence around atypical fractures.

Authors:  Bo Abrahamsen; Emma M Clark
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

Review 6.  Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.

Authors:  Beatrice J Edwards; Andrew D Bunta; Joseph Lane; Clarita Odvina; D Sudhaker Rao; Dennis W Raisch; June M McKoy; Imran Omar; Steven M Belknap; Vishvas Garg; Allison J Hahr; Athena T Samaras; Matthew J Fisher; Dennis P West; Craig B Langman; Paula H Stern
Journal:  J Bone Joint Surg Am       Date:  2013-02-20       Impact factor: 5.284

7.  Short-courses of dexamethasone abolish bisphosphonate-induced reductions in bone toughness.

Authors:  Tianyi D Luo; Matthew R Allen
Journal:  Bone       Date:  2013-06-14       Impact factor: 4.398

8.  The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.

Authors:  H Tsuchie; N Miyakoshi; K Iba; Y Kasukawa; K Nozaka; T Dohke; I Kosukegawa; T Aizawa; S Maekawa; H Abe; M Takeshima; T Tomite; T Segawa; K Ouchi; H Kinoshita; M Suzuki; T Yamashita; Y Shimada
Journal:  Osteoporos Int       Date:  2018-08-13       Impact factor: 4.507

9.  Atypical femoral fracture following bisphosphonate treatment in a woman with osteogenesis imperfecta--a case report.

Authors:  Raphael P H Meier; Kuntheavy Ing Lorenzini; Brigitte Uebelhart; Richard Stern; Robin E Peter; René Rizzoli
Journal:  Acta Orthop       Date:  2012-09-24       Impact factor: 3.717

10.  Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report.

Authors:  Ken Lee Puah; Mann Hong Tan
Journal:  Acta Orthop       Date:  2011-05-11       Impact factor: 3.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.